| 103 | 2 | 16 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 1.探讨杂合肾脏替代治疗(Hybrid Renal Replacement Therapy,HRRT)能否改善脓毒症合并急性肾损伤(Acute Kidney Injury,AKI)患者平均动脉压、心率及体温情况;2.探讨杂合肾脏替代治疗能否降低脓毒症合并AKI患者血浆降钙素原、白细胞、血乳酸水平。方法将2015-2017年收治的108例脓毒症合并AKI患者按随机数表法分为对照组和观察组。对照组给予脓毒症除血液净化外的常规治疗,观察组在对照组治疗的基础上加用HRRT治疗。比较两组治疗前后48 h的平均动脉压、心率、体温情况及血浆降钙素原、白细胞、血乳酸水平。结果治疗48 h后观察组心率、体温改善虽好于对照组,但差异不具有显著性(P> 0.05),但平均动脉压的改善明显优于对照组,且差异具有显著性(P <0.05)。治疗48 h后观察组白细胞下降水平差异不具有显著性(P> 0.05),但血乳酸及血浆降钙素原下降水平明显好于对照组,且差异具有显著性(P <0.05)。结论 1.杂合肾脏替代治疗有助于稳定脓毒症合并AKI患者的平均动脉压;2.杂合肾脏替代治疗可以降低脓毒症合并AKI患者血乳酸及血浆降钙素原水平。
Abstract：Objective 1. To explore whether the Hybrid Renal Replacement Therapy(HRRT)can improve the heart rate, mean artery pressure, and body temperature in patients with sepsis complicated with Acute Kidney Injury(AKI). 2. To investigate whether HRRT can reduce plasma procalcitonin, white blood cells and blood lactic acid levels in AKI patients with sepsis. Methods A total of 108 AKI patients with sepsis admitted from October 2015 to September 2017 were selected and randomly divided into a control group and an observation group according to treatment regimens. The control group was given conventional treatment, while the observation group was given HRRT adding to the conventional treatment. The heart rate, mean artery pressure, body temperature, plasma procalcitonin, white blood cells and blood lactic acid levels were compared between the observation group and the control group 48 hours before and after treatment. Results After 48 hours of treatment, although the improvement in body temperature and heart rate of the observation group was better than that of the control group, the difference was not statistically significant(P>0.05). The improvement in mean arterial pressure was significantly better than that of the control group, and the difference was statistically significant(P< 0.05). After 48 hours of treatment, the decrease of white blood cells in the observation group was not statistically significant(P>0.05), but the decrease of blood lactate and plasma procalcitonin were significantly better than those of the control group with statistical significance(P<0.05). Conclusion 1. HRRT can stabilize the mean arterial pressure in AKI patients with sepsis; 2. HRRT can reduce the serum lactic acid and plasma procalcitonin levels in AKI patients with sepsis.
[1] Zhou J, Qian C, Zhao M, et al. Epidemiology and Outcome of Severe Sepsis and Septic Shock in Intensive Care Units in China's mainland[J]. Plos One, 2014, 9(9):e107181. DOI:10.1371/journal.pone.0107181.
[2]付素珍.连续性血液净化对脓毒症患者免疫功能及预后的影响[J].实用医学杂志, 2014(17):2731-2734. DOI:10.3969/j.issn.1006-5725.2014.17.012.
[3] Helset E, Nordy I, Sporsem H, et al. Factors increasing the risk of inappropriate vancomycin therapy in ICU patients:A prospective observational study.[J].Acta Anaesthesiol Scand, 2020, 64:1295-1304. DOI:10.1111/aas.13658.
[4] Singer M, Deutschman C S, Seymour C W, et al. The Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3). JAMA. 2016. 315(8):801-810. DOI:10.1001/jama.2016.0287.
[5]王黎明,柴艳芬,董佳月,等.连续性血液净化治疗脓毒症临床疗效的Meta分析[J].中华危重症医学杂志:电子版, 2014,7(5):5-9. DOI:10.3877/cma.j.issn.1674-6880.2014.05.002.
[6] Fabbri A, Marchesini G, Benazzi B, et al. Old subjects with sepsis in the emergency department:trend analysis of case fatality rate.[J].BMC Geriatr, 2019, 19:372. DOI:10.1186/s12877-019-1384-8.
[7] EV Jiménez, Anumudu S J, Neyra J A. Dose of Continuous Renal Replacement Therapy in Critically Ill Patients:A Bona Fide Quality Indicator[J]. Nephron-Physiology, 2021, 145(2):1-8.DOI:10.1159/000512846.
[8]郝鹏,梁彦平,李晓峰,等.连续性血液透析滤过联合血液灌流在脓毒症合并急性肾损伤患者中的应用研究[J].中华灾害救援医学, 2019, 7(4):207-211. DOI:10.13919/j.issn.2095-6274.2019.04.007.
[9] K Boss, Jahn M, Wendt D, et al. Extracorporeal cytokine adsorption:Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery[J].PLoS ONE, 2021, 16(2):e0246299. DOI:10.1371/journal.pone.0246299.
[10] Lafever S, J López, R González, et al. Hemodynamic disturbances and oliguria during continuous kidney replacement therapy in critically ill children[J]. Pediatric Nephrology, 2021(Suppl 2). DOI:10.1007/s00467-020-04804-z.
[11] Minhua, Chen, Bangchuan, et al.[Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].[J]. Zhonghua wei zhong bing ji jiu yi xue, 2016, 28(3):246-51. DOI:10.3760/cma.j.issn.2095-4352.2016.03.011.
[12] Jagan N, Morrow L E, Walters R W, et al. Sympathetic stimulation increases serum lactate concentrations in patients admitted with sepsis:implications for resuscitation strategies.[J].Ann Intensive Care, 2021, 11(1):1-9. DOI:10.1186/s13613-021-00805-9.
[13] F Mariano, Biancone L. Metformin, chronic nephropathy and lactic acidosis:a multi-faceted issue for the nephrologist.[J].J Nephrol,2020, 1-9. DOI:10.1007/s40620-020-00941-8.
[14] Zhou T L, Zhou Y P, Zhang Y C, et al.[Clinical features and outcomes of cancer-related versus non-cancer-related sepsis in pediatric intensive care unit].[J].Zhonghua Er Ke Za Zhi, 2020,58:482-487. DOI:10.3760/cma.j.cn112140-20200211-00074.
[15] Lee H J, Son Y J. Factors Associated with In-Hospital Mortality after Continuous Renal Replacement Therapy for Critically Ill Patients:A Systematic Review and Meta-Analysis[J]. International Journal of Environmental Research and Public Health, 2020, 17(23):8781. DOI:10.3390/ijerph17238781.
[16] Zhang Y, Shao D R, He Z P, et al. Efficacy of continuous renal replacement on acute renal injury developed in severe sepsis.[J].J Biol Regul Homeost Agents, 2019, 33:525-530.
基本信息:
DOI：10.13919/j.issn.2095-6274.2021.06.005
中图分类号:R692;R459.7
引用信息:
[1]郝鹏,李旭,李晓峰,等.杂合肾脏替代治疗对脓毒症合并急性肾损伤患者生命体征及感染指标的影响[J].中华灾害救援医学,2021,9(06):1041-1045.DOI:10.13919/j.issn.2095-6274.2021.06.005.
基金信息:
新疆生产建设兵团科技成果重点推广计划（2016AD004）
2021-06-15
2021-06-15